Filing Details

Accession Number:
0001562180-18-004443
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-07 16:02:10
Reporting Period:
2018-10-30
Accepted Time:
2018-11-07 16:02:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1395937 Syndax Pharmaceuticals Inc SNDX Pharmaceutical Preparations (2834) 320162505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1664204 L. Michael Meyers C/O Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive, Building D, Floor 3
Waltham MA 02451
Svp, Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-10-30 200 $4.79 2,398 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 2,198 shares acquired under the Syndax Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan on 7/31/2018.